KR970065511A - 오르토-치환된 벤조일구아니딘, 이의 제조방법, 약제 또는 진단제로서의 이의 용도 및 이를 포함하는 약제 - Google Patents
오르토-치환된 벤조일구아니딘, 이의 제조방법, 약제 또는 진단제로서의 이의 용도 및 이를 포함하는 약제 Download PDFInfo
- Publication number
- KR970065511A KR970065511A KR1019970006865A KR19970006865A KR970065511A KR 970065511 A KR970065511 A KR 970065511A KR 1019970006865 A KR1019970006865 A KR 1019970006865A KR 19970006865 A KR19970006865 A KR 19970006865A KR 970065511 A KR970065511 A KR 970065511A
- Authority
- KR
- South Korea
- Prior art keywords
- carbon atoms
- substituted
- formula
- compound
- alkyl
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Ceased
Links
- AJDQRQQNNLZLPM-UHFFFAOYSA-N n-(diaminomethylidene)benzamide Chemical class NC(N)=NC(=O)C1=CC=CC=C1 AJDQRQQNNLZLPM-UHFFFAOYSA-N 0.000 title claims abstract 3
- 239000003814 drug Substances 0.000 title claims 12
- 239000003795 chemical substances by application Substances 0.000 title 1
- 239000000032 diagnostic agent Substances 0.000 title 1
- 229940039227 diagnostic agent Drugs 0.000 title 1
- 150000001875 compounds Chemical class 0.000 claims abstract 17
- 238000011282 treatment Methods 0.000 claims abstract 11
- 230000000302 ischemic effect Effects 0.000 claims abstract 5
- 230000002265 prevention Effects 0.000 claims abstract 4
- 206010002383 Angina Pectoris Diseases 0.000 claims abstract 2
- 125000004432 carbon atom Chemical group C* 0.000 claims 40
- -1 biphenylyl Chemical group 0.000 claims 23
- 125000001424 substituent group Chemical group 0.000 claims 18
- 125000000217 alkyl group Chemical group 0.000 claims 14
- 125000000753 cycloalkyl group Chemical group 0.000 claims 11
- 229910052739 hydrogen Inorganic materials 0.000 claims 10
- 238000004519 manufacturing process Methods 0.000 claims 8
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 claims 8
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 claims 7
- 125000001072 heteroaryl group Chemical group 0.000 claims 6
- 239000001257 hydrogen Substances 0.000 claims 6
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 claims 5
- 125000003545 alkoxy group Chemical group 0.000 claims 5
- 125000000956 methoxy group Chemical group [H]C([H])([H])O* 0.000 claims 5
- 150000003839 salts Chemical class 0.000 claims 5
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical group [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 claims 3
- 125000000000 cycloalkoxy group Chemical group 0.000 claims 3
- 125000002147 dimethylamino group Chemical group [H]C([H])([H])N(*)C([H])([H])[H] 0.000 claims 3
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 claims 3
- 125000002887 hydroxy group Chemical group [H]O* 0.000 claims 3
- 125000001624 naphthyl group Chemical group 0.000 claims 3
- 229910052760 oxygen Inorganic materials 0.000 claims 3
- 239000001301 oxygen Substances 0.000 claims 3
- 201000010099 disease Diseases 0.000 claims 2
- 125000004433 nitrogen atom Chemical group N* 0.000 claims 2
- 238000011321 prophylaxis Methods 0.000 claims 2
- 125000004169 (C1-C6) alkyl group Chemical group 0.000 claims 1
- 125000006552 (C3-C8) cycloalkyl group Chemical group 0.000 claims 1
- VPKHEPKNSNNZOC-UHFFFAOYSA-N 2,6-dichloro-n-(diaminomethylidene)benzamide;hydrochloride Chemical compound Cl.NC(=N)NC(=O)C1=C(Cl)C=CC=C1Cl VPKHEPKNSNNZOC-UHFFFAOYSA-N 0.000 claims 1
- 201000001320 Atherosclerosis Diseases 0.000 claims 1
- 206010010904 Convulsion Diseases 0.000 claims 1
- 206010019280 Heart failures Diseases 0.000 claims 1
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 claims 1
- 206010023421 Kidney fibrosis Diseases 0.000 claims 1
- 206010028980 Neoplasm Diseases 0.000 claims 1
- 206010034576 Peripheral ischaemia Diseases 0.000 claims 1
- 125000004429 atom Chemical group 0.000 claims 1
- 201000011510 cancer Diseases 0.000 claims 1
- 230000004663 cell proliferation Effects 0.000 claims 1
- 210000003169 central nervous system Anatomy 0.000 claims 1
- 208000019425 cirrhosis of liver Diseases 0.000 claims 1
- 206010012601 diabetes mellitus Diseases 0.000 claims 1
- 230000006806 disease prevention Effects 0.000 claims 1
- 230000003176 fibrotic effect Effects 0.000 claims 1
- 238000009472 formulation Methods 0.000 claims 1
- 150000002431 hydrogen Chemical class 0.000 claims 1
- 239000007943 implant Substances 0.000 claims 1
- 125000005956 isoquinolyl group Chemical group 0.000 claims 1
- 125000000250 methylamino group Chemical group [H]N(*)C([H])([H])[H] 0.000 claims 1
- 239000000203 mixture Substances 0.000 claims 1
- UNFXZTUFUAETRQ-UHFFFAOYSA-N n-(diaminomethylidene)-4-hydroxy-2-methyl-5-(trifluoromethyl)benzamide;hydrochloride Chemical compound Cl.CC1=CC(O)=C(C(F)(F)F)C=C1C(=O)NC(N)=N UNFXZTUFUAETRQ-UHFFFAOYSA-N 0.000 claims 1
- 210000000056 organ Anatomy 0.000 claims 1
- 230000002093 peripheral effect Effects 0.000 claims 1
- 210000001428 peripheral nervous system Anatomy 0.000 claims 1
- 150000003018 phosphorus compounds Chemical class 0.000 claims 1
- 210000002307 prostate Anatomy 0.000 claims 1
- 208000005069 pulmonary fibrosis Diseases 0.000 claims 1
- 125000004076 pyridyl group Chemical group 0.000 claims 1
- 125000005493 quinolyl group Chemical group 0.000 claims 1
- 230000008719 thickening Effects 0.000 claims 1
- 238000002054 transplantation Methods 0.000 claims 1
- 206010061216 Infarction Diseases 0.000 abstract 1
- 239000003416 antiarrhythmic agent Substances 0.000 abstract 1
- 230000003293 cardioprotective effect Effects 0.000 abstract 1
- 230000007574 infarction Effects 0.000 abstract 1
- 230000001575 pathological effect Effects 0.000 abstract 1
- 230000035790 physiological processes and functions Effects 0.000 abstract 1
- 230000000069 prophylactic effect Effects 0.000 abstract 1
- 210000003462 vein Anatomy 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C279/00—Derivatives of guanidine, i.e. compounds containing the group, the singly-bound nitrogen atoms not being part of nitro or nitroso groups
- C07C279/20—Derivatives of guanidine, i.e. compounds containing the group, the singly-bound nitrogen atoms not being part of nitro or nitroso groups containing any of the groups, X being a hetero atom, Y being any atom, e.g. acylguanidines
- C07C279/22—Y being a hydrogen or a carbon atom, e.g. benzoylguanidines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/08—Drugs for disorders of the urinary system of the prostate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P41/00—Drugs used in surgical methods, e.g. surgery adjuvants for preventing adhesion or for vitreum substitution
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/06—Antiarrhythmics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/08—Vasodilators for multiple indications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Medicinal Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Diabetes (AREA)
- Urology & Nephrology (AREA)
- Emergency Medicine (AREA)
- Hematology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Surgery (AREA)
- Vascular Medicine (AREA)
- Endocrinology (AREA)
- Biomedical Technology (AREA)
- Obesity (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Agricultural Chemicals And Associated Chemicals (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE19608161.0 | 1996-03-04 | ||
| DE19608161A DE19608161A1 (de) | 1996-03-04 | 1996-03-04 | Ortho-substituierte Benzoylguanidine, Verfahren zu ihrer Herstellung, ihre Verwendung als Medikament oder Diagnostikum sowie sie enthaltendes Medikament |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| KR970065511A true KR970065511A (ko) | 1997-10-13 |
Family
ID=7787087
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| KR1019970006865A Ceased KR970065511A (ko) | 1996-03-04 | 1997-03-03 | 오르토-치환된 벤조일구아니딘, 이의 제조방법, 약제 또는 진단제로서의 이의 용도 및 이를 포함하는 약제 |
Country Status (30)
| Country | Link |
|---|---|
| US (1) | US6262123B1 (enExample) |
| EP (1) | EP0794172B1 (enExample) |
| JP (1) | JP4039586B2 (enExample) |
| KR (1) | KR970065511A (enExample) |
| CN (1) | CN1071318C (enExample) |
| AR (1) | AR006051A1 (enExample) |
| AT (1) | ATE207462T1 (enExample) |
| AU (1) | AU707619B2 (enExample) |
| BR (1) | BR9701159A (enExample) |
| CA (1) | CA2198980A1 (enExample) |
| CZ (1) | CZ293144B6 (enExample) |
| DE (2) | DE19608161A1 (enExample) |
| DK (1) | DK0794172T3 (enExample) |
| ES (1) | ES2166481T3 (enExample) |
| HR (1) | HRP970125B1 (enExample) |
| HU (1) | HUP9700542A3 (enExample) |
| ID (1) | ID16106A (enExample) |
| IL (1) | IL120358A (enExample) |
| MX (1) | MX9701619A (enExample) |
| MY (1) | MY116861A (enExample) |
| NO (1) | NO308793B1 (enExample) |
| NZ (1) | NZ314325A (enExample) |
| PL (1) | PL185751B1 (enExample) |
| PT (1) | PT794172E (enExample) |
| RU (1) | RU2212400C2 (enExample) |
| SI (1) | SI0794172T1 (enExample) |
| SK (1) | SK283934B6 (enExample) |
| TR (1) | TR199700131A2 (enExample) |
| TW (1) | TW440558B (enExample) |
| ZA (1) | ZA971815B (enExample) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE10001879A1 (de) * | 2000-01-19 | 2001-07-19 | Aventis Pharma Gmbh | Substituierte Benzoylguanidine, Verfahren zu ihrer Herstellung, ihre Verwendung als Medikament oder Diagnostikum sowie sie enthaltendes Medikament |
| CN100371328C (zh) * | 2006-01-19 | 2008-02-27 | 中国药科大学 | 取代苯甲酰基胍衍生物、其制备方法及其医药用途 |
Family Cites Families (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CZ284456B6 (cs) * | 1992-02-15 | 1998-12-16 | Hoechst Aktiengesellschaft | Aminosubstituované benzoylguanidiny, způsob jejich přípravy, jejich použití jako léčiv a léčivo, které je obsahuje |
| TW250477B (enExample) | 1992-12-15 | 1995-07-01 | Hoechst Ag | |
| DE59403818D1 (de) | 1993-02-20 | 1997-10-02 | Hoechst Ag | Substituierte Benzoylguanidine, Verfahren zu ihrer Herstellung, ihre Verwendung als Medikament, als Inhibitoren des zellulären Na+/H+-Austauschs oder als Diagnostikum sowie sie enthaltendes Medikament |
| DE4318756A1 (de) | 1993-06-05 | 1994-12-08 | Hoechst Ag | Substituierte Benzoylguanidine, Verfahren zu ihrer Herstellung, ihre Verwendung als Medikament oder Diagnostikum sowie sie enthaltendes Medikament |
| DE4328869A1 (de) * | 1993-08-27 | 1995-03-02 | Hoechst Ag | Ortho-substituierte Benzoylguanidine, Verfahren zu ihrer Herstellung, ihre Verwendung als Medikament oder Diagnostikum sowie sie enthaltendes Medikament |
| DE4404183A1 (de) * | 1994-02-10 | 1995-08-17 | Merck Patent Gmbh | 4-Amino-1-piperidylbenzoylguanidine |
| DE4417004A1 (de) | 1994-05-13 | 1995-11-16 | Hoechst Ag | Perfluoralkyl-substituierte Benzoylguanidine, Verfahren zu ihrer Herstellung, ihre Verwendung als Medikament oder Diagnostikum sowie sie enthaltendes Medikament |
| DE4421495A1 (de) * | 1994-06-20 | 1995-12-21 | Merck Patent Gmbh | Heterocyclyloxy-benzoylguanidine |
| DE4422685A1 (de) * | 1994-06-29 | 1996-01-04 | Hoechst Ag | Ortho-amino-substituierte Benzoylguanidine, Verfahren zu ihrer Herstellung, ihre Verwendung als Medikament oder Diagnostikum sowie sie enthaltendes Medikament |
| DE4430213A1 (de) * | 1994-08-28 | 1996-02-29 | Merck Patent Gmbh | Arylbenzoylguanidine |
| DE4430861A1 (de) * | 1994-08-31 | 1996-03-07 | Merck Patent Gmbh | Heterocyclyl-benzoylguanidine |
| DE19517848A1 (de) * | 1995-05-16 | 1996-11-21 | Merck Patent Gmbh | Fluorhaltige Benzoylguanidine |
| DE19531138A1 (de) * | 1995-08-24 | 1997-02-27 | Merck Patent Gmbh | Alkenyl-benzoylguanidin-Derivate |
| DE19624178A1 (de) * | 1996-06-18 | 1998-01-08 | Hoechst Ag | Ortho-substituierte Benzoylguanidine, Verfahren zu ihrer Herstellung ihre Verwendung als Medikament oder Diagnostikum sowie sie enthaltendes Medikament |
-
1996
- 1996-03-04 DE DE19608161A patent/DE19608161A1/de not_active Withdrawn
-
1997
- 1997-02-11 PL PL97318415A patent/PL185751B1/pl not_active IP Right Cessation
- 1997-02-19 ES ES97102607T patent/ES2166481T3/es not_active Expired - Lifetime
- 1997-02-19 DK DK97102607T patent/DK0794172T3/da active
- 1997-02-19 DE DE59705019T patent/DE59705019D1/de not_active Expired - Lifetime
- 1997-02-19 PT PT97102607T patent/PT794172E/pt unknown
- 1997-02-19 AT AT97102607T patent/ATE207462T1/de not_active IP Right Cessation
- 1997-02-19 EP EP97102607A patent/EP0794172B1/de not_active Expired - Lifetime
- 1997-02-19 SI SI9730252T patent/SI0794172T1/xx unknown
- 1997-02-27 TW TW086102369A patent/TW440558B/zh not_active IP Right Cessation
- 1997-02-28 CN CN97102833A patent/CN1071318C/zh not_active Expired - Fee Related
- 1997-02-28 AR ARP970100820A patent/AR006051A1/es unknown
- 1997-02-28 NZ NZ314325A patent/NZ314325A/en unknown
- 1997-02-28 AU AU14997/97A patent/AU707619B2/en not_active Ceased
- 1997-02-28 SK SK276-97A patent/SK283934B6/sk unknown
- 1997-03-03 TR TR97/00131A patent/TR199700131A2/xx unknown
- 1997-03-03 CZ CZ1997654A patent/CZ293144B6/cs not_active IP Right Cessation
- 1997-03-03 CA CA002198980A patent/CA2198980A1/en not_active Abandoned
- 1997-03-03 KR KR1019970006865A patent/KR970065511A/ko not_active Ceased
- 1997-03-03 NO NO970963A patent/NO308793B1/no unknown
- 1997-03-03 MX MX9701619A patent/MX9701619A/es not_active IP Right Cessation
- 1997-03-03 ID IDP970641A patent/ID16106A/id unknown
- 1997-03-03 RU RU97103361/04A patent/RU2212400C2/ru not_active IP Right Cessation
- 1997-03-03 ZA ZA9701815A patent/ZA971815B/xx unknown
- 1997-03-03 JP JP04747997A patent/JP4039586B2/ja not_active Expired - Fee Related
- 1997-03-03 BR BR9701159A patent/BR9701159A/pt not_active Application Discontinuation
- 1997-03-03 MY MYPI97000835A patent/MY116861A/en unknown
- 1997-03-03 HR HR970125A patent/HRP970125B1/xx not_active IP Right Cessation
- 1997-03-03 IL IL12035897A patent/IL120358A/en not_active IP Right Cessation
- 1997-03-04 HU HU9700542A patent/HUP9700542A3/hu unknown
-
1999
- 1999-09-17 US US09/398,196 patent/US6262123B1/en not_active Expired - Fee Related
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| KR910006225A (ko) | 벤조일구아니딘, 이의 제조방법. 약제로서의 이의 용도 및 이를 함유하는 약제 | |
| KR970025611A (ko) | 치환된 설폰이미다미드, 이의 제조방법,약제 또는 진단제로서의 이의 용도 및 이를 함유하는 약제 | |
| DE59704609D1 (de) | Verfahren zur herstellung von lithium-borat-komplexen | |
| JP2007516180A5 (enExample) | ||
| CA2669481A1 (en) | Substituted 2-(2,6-dioxopiperidin-3-yl)-phthalimides and -1-oxoisoindolines and method of reducing tnf.alpha. levels | |
| ZA200308520B (en) | Anthranilac acid amides with a heteroarylsulfonyl side chain, method for the production thereof, use thereof as a medicament or diagnostic agent and pharmaceutical preparations containing said compounds. | |
| CA1120058A (en) | Phenethanolamines, formulations and potentiation of oncolytic drugs | |
| RU95113107A (ru) | Новые пирролокарбазолы | |
| KR920002580A (ko) | 카르보스티릴 유도체 | |
| RU2003134629A (ru) | Соединения цефема | |
| PL118755B1 (en) | Process for preparing novel derivatives of phenethanolamine | |
| KR980002019A (ko) | 오르토-치환된 벤조일구아니딘, 이의 제법, 약제 또는 진단제로서의 이의 용도 및 이를 포함하는 약제 | |
| CA2357038A1 (en) | Medical compositions comprising 1,4-benzothiazepine derivatives for the treatment of atrial fibrillation | |
| KR970074776A (ko) | 치환된 2-나프토일구아니딘, 이의 제조방법, 약물 또는 진단제로서의 이의 용도 및 이를 함유하는 약제 | |
| RU94045156A (ru) | Применение 2-фенил-3-ароилбензотиофенов для ингибирования преждевременного полового созревания | |
| JPH1067731A5 (enExample) | ||
| KR970015568A (ko) | 치환된 벤조일구아니딘, 이의 제조방법, 약제 또는 진단제로서의 이의 용도 및 이를 포함하는 약제 | |
| MX9200485A (es) | Proceso para la obtencion de derivados de tetra hidro piridina y composicion farmaceutica que los contiene. | |
| RU2208611C2 (ru) | Сульфонамидозамещенные хроманы и фармацевтическая композиция | |
| KR970065512A (ko) | 오르토-치환된 벤조일구아니딘, 이의 제조방법, 약제 또는 진단제로서의 이의 용도, 및 이를 포함하는 약제 | |
| EP1245561A1 (en) | N-substituted benzyl or phenyl aromatic sulfamides compounds and the use thereof | |
| KR970026597A (ko) | 설포닐아미노-치환된 벤조일구아니딘, 이의 제조 방법, 약제 또는 진단 보조제로서의 이의 용도 및 이를 함유하는 약제 | |
| KR970061887A (ko) | 치환된 티오페닐알케닐카복실산 구아니디드, 이의 제조방법, 약물 및 진단제로서의 이의 용도 및 이를 함유하는 약제 | |
| CA2025858A1 (en) | Antihepatopathic composition | |
| KR970074756A (ko) | 비스-오르토-치환된 벤조일구아니딘, 이의 제조 방법, 약제 또는 진단제로서의 이의 용도 및 이를 함유하는 약제 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PA0109 | Patent application |
Patent event code: PA01091R01D Comment text: Patent Application Patent event date: 19970303 |
|
| PG1501 | Laying open of application | ||
| A201 | Request for examination | ||
| PA0201 | Request for examination |
Patent event code: PA02012R01D Patent event date: 20020228 Comment text: Request for Examination of Application Patent event code: PA02011R01I Patent event date: 19970303 Comment text: Patent Application |
|
| E902 | Notification of reason for refusal | ||
| PE0902 | Notice of grounds for rejection |
Comment text: Notification of reason for refusal Patent event date: 20040623 Patent event code: PE09021S01D |
|
| E601 | Decision to refuse application | ||
| PE0601 | Decision on rejection of patent |
Patent event date: 20050418 Comment text: Decision to Refuse Application Patent event code: PE06012S01D Patent event date: 20040623 Comment text: Notification of reason for refusal Patent event code: PE06011S01I |
|
| J201 | Request for trial against refusal decision | ||
| PJ0201 | Trial against decision of rejection |
Patent event date: 20050719 Comment text: Request for Trial against Decision on Refusal Patent event code: PJ02012R01D Patent event date: 20050418 Comment text: Decision to Refuse Application Patent event code: PJ02011S01I Appeal kind category: Appeal against decision to decline refusal Decision date: 20061010 Appeal identifier: 2005101004669 Request date: 20050719 |
|
| J801 | Dismissal of trial |
Free format text: REJECTION OF TRIAL FOR APPEAL AGAINST DECISION TO DECLINE REFUSAL REQUESTED 20050719 Effective date: 20061010 |
|
| PJ0801 | Rejection of trial |
Patent event date: 20061010 Patent event code: PJ08011S01D Comment text: Decision on Dismissal of Request for Trial (Dismissal of Decision) Decision date: 20061010 Appeal kind category: Appeal against decision to decline refusal Appeal identifier: 2005101004669 Request date: 20050719 |